Daniel Behr is CEO of SLIPS Technologies, a venture-funded Harvard spinoff commercializing advanced materials and coatings. Daniel is also co-founder of Rediscovery Life Sciences, a company developing new pharmaceuticals via drug repurposing, and a Director of the Institute for Biomedical Entrepreneurship. He brings over 25 years of experience moving innovations from lab to market in the life sciences and the physical sciences – mostly through his involvement in dozens of startups as serial entrepreneur, venture investor and technology transfer professional. He was a co-founder and Senior VP of Access BridgeGap Ventures, a Director of Technology Ventures at Allied Minds, and a Director of Business Development at Harvard University’s Office of Technology Development. Prior to that Daniel co-founded In-USA (ozone instrumentation), Compact Instruments (mass spectrometers), Arradiance (atomic layer deposition) and Seed Partners (seed-stage angel fund). Before starting his first company, Daniel was a Consultant at Bain & Co. and a Materials Research Engineer at Albany International. He holds an engineering degree from Georgia Tech and an MBA from the Harvard Business School, and he speaks Spanish and German.
SLIPS Technologies, Inc.